TLM19 Nov 2020 19:27
Toploader Mike07 Nov 2020 19:34
I think I may have ****ed you off.
Can I extend my apology .
"I've been doing some research using my resources on the MM's Order Book valuations/levels for RMS, and it looks to me as though they are only just starting to wake up as to the potential for this co. Profit and loss figures are great in a financial concept but they don't, and cannot determine the future of a new technology aware solution that combats a new disease. Big Pharmaceutical company's spend billions per year on R&D looking for a new solution to something that is much lesser a threat, and even after spending those billions they are rarely successful in introducing those solutions, mainly due to restrictions in place by global variable regulations. If the Take Over of P2F is successful, and if the results from NU are as we believe they will be, I can't see any downside in this co, and I think the recent OB pricing and lack of available shares via the MMs is showing this to be the case. Yes of course when someone offloads a 2.5M lump the MMs have some spare, but you only have to look at the volumes to see that when those shares are gobbled up "the can't buy shares" scenario appears again.
With our demand for new solutions, including renewable solutions for energy supply's and delivery, I can only see this co as a "got to have and hold) share. No investment advise given in my comments, which are that of my own.
TLM